Compare Charles River Laboratories Intl. Inc (CRL) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Wells Fargo & Co — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Wells Fargo & Co trades at $83.55 (market cap $248.06B). The key difference: Wells Fargo & Co is far larger — about 17.4× Charles River Laboratories Intl. Inc's market cap, and Wells Fargo & Co pays a 2.44% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Wells Fargo & Co for 88 Days on average.
| CRL | WFC | |
|---|---|---|
Market Cap | $14.23B | $248.06B |
Volume | 1,176,885 | 16,615,741 |
Sector | Health | Financials |
52-Week High | $310.77 | $96.40 |
52-Week Low | $149.93 | $73.42 |
Typical Hold Time | 33 Days | 88 Days |
Enterprise Value | $17.06B | $503.91B |
Dividend Yield | — | 2.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.
CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.
Wells Fargo (WFC) trades at $82.06, up 2.24% on the day, with a bearish technical signal from moving averages. The stock's valuation appears attractive with a P/E of 11.92 and P/B of 1.5, while profitability remains strong with a 25.97% net income margin. Recent news includes a credit rating upgrade to 'A-' by S&P (Zacks Investment Research, 2026-10-01) and upcoming Q3 earnings on October 13, 2026 (Benzinga, 2026-09-29).
The outlook is mixed: analyst consensus targets $99.13 (46.66% buy ratings), but recent earnings misses and a negative cash flow trend in 2025 pose risks. Upside potential hinges on execution amid Fed policy changes and competitive pressures in the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
